<DOC>
	<DOCNO>NCT02660333</DOCNO>
	<brief_summary>The purpose study evaluate effect prebiotic synbiotic supplementation inflammatory response indicator nutritional status patient morbid obesity . Study hypothesis : Supplementation 12 g/day fructooligosaccharides ( prebiotic ) 12 g/day fructooligosaccharides + strain lactobacilli bifidobacteria ( synbiotic ) 30 day promote reduction plasma/serum level acute phase protein , cytokine , metabolic anthropometric parameter individual BMI ≥ 40kg/m² .</brief_summary>
	<brief_title>Effect Prebiotic Synbiotic Inflammatory Response Indicators Nutritional Status Obesity</brief_title>
	<detailed_description>The purpose study evaluate effect prebiotic synbiotic supplementation inflammatory response indicator nutritional status patient morbid obesity . Adult individual sex morbid obesity ( body mass index ≥ 40 kg/m² ) invite participate randomize , placebo-controlled , triple-blind study . The participant divide three group : G1 - control group ( placebo ) , G2 - prebiotic group G3 - synbiotic group . The study consist four experimental time point : M0 - baseline start supplementation ; M1 - fifteen day first outpatient visit fifteen day start supplementation prebiotic , synbiotic placebo ; M2 - thirty day first outpatient visit end supplementation prebiotic , synbiotic placebo ; M3 - time sixty day first outpatient visit . At time point inflammatory response assess determination plasma cytokine ( IL-1 , IL-6 , IL-10 , TNF ) acute phase protein ( c-reactive protein albumin ) , besides evaluation laboratory anthropometric indicator nutritional status . The primary endpoint reduction concentration inflammatory marker ( cytokine acute phase protein ) . Investigators expect contribute new information field knowledge , may facilitate clinical application result .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Obesity , Morbid</mesh_term>
	<criteria>Age great 18 year less 60 year Body mass index ( BMI ) ≥40kg/m2 Previous gastrointestinal disease ( e.g . cancer inflammatory bowel disease ) Intolerances and/or food allergy ( e.g . lactose intolerance celiac disease ) Current use antiinflammatory drug and/or antibiotic and/or immunosuppressant Regular use laxatives and/or appetite suppressant Current previous use ( one month ) prebiotics , probiotic , synbiotics product enrich food compound Intolerance prebiotic and/or probiotic and/or synbiotic Following diet weight loss last three month Pregnant breastfeed Following unusual diet ( e.g . vegetarian , macrobiotic ) Alcohol dependence and/or illicit drug dependence Smokers</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Nutritional status</keyword>
	<keyword>Prebiotic</keyword>
	<keyword>Synbiotic</keyword>
</DOC>